Factors Predicting Abnormal Liver Function Tests Induced by Graves’ Disease Alone
Authors:
- Ruiguo ZhangRZRuiguo Zhang
- Xun TianXTXun Tian
- Lan QinLQLan Qin
- Xiaoer WeiXWXiaoer Wei
- Junqi WangJWJunqi Wang
- Jie ShenJSJie Shen
Open Access
- 1 May 2015
- journal article
- research article
- Published by Wolters Kluwer Health in Medicine
- Vol. 94 (19) , e839-6
Abstract
Abnormal liver function tests (LFTs) are often observed in patients with Graves’ disease (GD). To date, there are limited data demonstrating the factors or biochemical indexes contributing to LFT abnormalities in this patient population. The aim of this study was to explore factors predicting abnormal LFTs induced by GD alone. This was a retrospective study of 289 consecutive cases of newly diagnosed and untreated patients with GD. All patients were divided into abnormal LFTs (group A) and normal LFTs (group B). In total, 205 (70.9%) cases were found to have at least 1 LFT abnormality. Among them, the frequencies of ALT, AST, ALP, γ-GTP, TBIL and DBIL abnormalities were 52.7%, 32.2%, 45.9%, 38.5%, 23.4%, 2.9%, respectively, and the number of patients with 1 to 6 hepatic variable abnormalities were 89, 64, 30, 16, 6 and 0, respectively. Logistic regression analysis was used to determine predictive factors contributing to abnormal LFTs. A receiver operating characteristic (ROC) curve was also plotted to verify the accuracy of predictors. In the univariate analysis, patients in group A had significantly higher FT3 concentration (37.5 vs 33.4 pmol/L, P = 0.009), FT4 concentration (85.7 vs 77.4 pmol/L, P = 0.002) and TRAb level (22.2 vs 17.4 IU/L, P < 0.001) when compared with those in group B. Binary logistic regression analysis identified higher FT4 concentration (odds ratio [OR]: 1.017, 95% confidence interval [CI]: 1.005–1.030, P = 0.006) and higher TRAb value (OR: 1.038, 95% CI:1.013–1.064, P = 0.003) to be independent risk factors predicting abnormal LFTs. The optimal cutoffs for FT4 and TRAb to predict abnormal LFTs were 75 pmol/L and 15 IU/L, respectively, based on ROC analysis.Keywords
This publication has 32 references indexed in Scilit:
- Clinical spectrum and therapeutic approach to hepatocellular injury in patients with hyperthyroidismClinical and Experimental Gastroenterology, 2013
- Hepatic Dysfunction in Hospitalized Patients with Acute Thyrotoxicosis: A Decade of ExperienceISRN Endocrinology, 2012
- Inverse Association Between Serum Free Thyroxine Levels and Hepatic Steatosis: Results from the Study of Health in PomeraniaThyroid®, 2012
- Graves' Disease: Diagnostic and Therapeutic Challenges (Multimedia Activity)The American Journal of Medicine, 2011
- Presence of thyrotropin receptor in hepatocytes: not a case of illegitimate transcriptionJournal of Cellular and Molecular Medicine, 2009
- Serial Changes in Liver Function Tests in Patients with Thyrotoxicosis Induced by Graves' Disease and Painless ThyroiditisThyroid®, 2008
- Association between serum TSH, free T4 and serum liver enzyme activities in a large cohort of unselected outpatientsClinical Endocrinology, 2007
- Effect of hyperthyroidism and propylthiouracil treatment on liver biochemical testsInternational Journal Of Clinical Practice, 2005
- Autoimmune Hepatitis Associated with Graves' DiseaseInternal Medicine, 2003
- GUY'S HOSPITAL.The Lancet, 1874